BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 30762947)

  • 21. Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study.
    Bauer PR; Schiavo DN; Osborn TG; Levin DL; St Sauver J; Hanson AC; Schroeder DR; Ryu JH
    Chest; 2013 Aug; 144(2):571-577. PubMed ID: 23450327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.
    Hoffmann-Vold AM; Fretheim H; Halse AK; Seip M; Bitter H; Wallenius M; Garen T; Salberg A; Brunborg C; Midtvedt Ø; Lund MB; Aaløkken TM; Molberg Ø
    Am J Respir Crit Care Med; 2019 Nov; 200(10):1258-1266. PubMed ID: 31310156
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lung involvement in systemic sclerosis].
    Posa M; Stelle M; Lador F; Chizzolini C
    Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.
    Mismetti V; Delavenne X; Montani D; Bezzeghoud S; Delezay O; Hodin S; Launay D; Marchand-Adam S; Nunes H; Ollier E; Reynaud-Gaubert M; Pastre J; Traclet J; Quetant S; Zeghmar S; Bertoletti L; Cottin V
    Respir Res; 2023 Nov; 24(1):273. PubMed ID: 37936223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Valenzuela A; Nandagopal S; Steen VD; Chung L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
    Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
    Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
    Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
    Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation and management approaches for scleroderma lung disease.
    Schoenfeld SR; Castelino FV
    Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.
    Fischer A; Misumi S; Curran-Everett D; Meehan RT; Ulrich SK; Swigris JJ; Frankel SK; Cosgrove GP; Lynch DA; Brown KK
    Chest; 2007 Apr; 131(4):988-92. PubMed ID: 17426200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung transplantation in systemic sclerosis: A single center cohort study.
    Fernández-Codina A; Berastegui C; Pinal-Fernández I; Silveira MG; López-Meseguer M; Monforte V; Guillén-Del Castillo A; Simeón-Aznar CP; Fonollosa-Plà V; Solé J; Bravo-Masgoret C; Román-Broto A
    Joint Bone Spine; 2018 Jan; 85(1):79-84. PubMed ID: 28408277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung and gastrointestinal complications are leading causes of death in SCORE, a multi-ethnic Singapore systemic sclerosis cohort.
    Santosa A; Tan CS; Teng GG; Fong W; Lim A; Law WG; Chan G; Ng SC; Low A
    Scand J Rheumatol; 2016 Nov; 45(6):499-506. PubMed ID: 27232525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease.
    Kwon HM; Kang EH; Park JK; Go DJ; Lee EY; Song YW; Lee HJ; Lee EB
    Rheumatology (Oxford); 2015 Oct; 54(10):1792-6. PubMed ID: 25972389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
    Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study.
    Bernstein EJ; Peterson ER; Sell JL; D'Ovidio F; Arcasoy SM; Bathon JM; Lederer DJ
    Arthritis Rheumatol; 2015 May; 67(5):1314-22. PubMed ID: 25581250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression.
    Guler SA; Winstone TA; Murphy D; Hague C; Soon J; Sulaiman N; Li KH; Dunne J; Wilcox PG; Ryerson CJ
    Ann Am Thorac Soc; 2018 Dec; 15(12):1427-1433. PubMed ID: 30188737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease.
    Chung JH; Walker CM; Hobbs S
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32744514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.